Novo Nordisk Estonia OÜ

Osaühing · 16722379 · Registrisse kantud

Activity

Novo Nordisk Estonia OÜ is a medium enterprise in trade, with declared activity “Ravimite ja muude apteegikaupade hulgimüük” (EMTAK 46461). Annual revenue stands at 28.23 M € with 18 employees, ranks #207 of 27,752 in trade.

Trade

Overview (2024)

Revenue
28.23 M €
▲ 368%YoY
▲ 1165×above industry median
Profit
1.01 M €
▲ 366%YoY
Profit margin
3.6%
Employees
18
▲ 12.5%YoY
Revenue per employee
1.57 M €
Cost per employee
95.4 k €
Equity
1.43 M €

Growth

Revenue
28.23 M €
▲ 368%
1y
—
3y CAGR
—
5y CAGR
Profit
1.01 M €
▲ 366%
1y
—
3y CAGR
—
5y CAGR
Employees
18
▲ 12.5%
1y
—
3y CAGR
—
5y CAGR

Trends

Revenue trend
28.23 M €
Profit trend
1.01 M €
Headcount trend
18

Revenue to profit

28.2 M €Revenue−1.7 M €Labor cost−25.5 M €Other costs1.0 M €Profit

Capital structure

  • Equity19%
  • Liabilities81%

Financials

YearRevenueGrowthProfitMarginEmployeesRevenue per employeeEquity
2024 ✓28.23 M €▲ 368%1.01 M €4%181.57 M €1.43 M €
2023 ✓6.03 M €—217.4 k €4%16376.7 k €417.4 k €

Similar companies

Same industry, comparable revenue.

Official announcements

Bankruptcy notices, liquidation notices, and other official statements about the company.

View announcements on Ametlikud Teadaanded →

Court rulings

Public court decisions where the company or its registry code is mentioned.

Search court rulings on Riigi Teataja →

General info

Shareholders

Equity holders ranked by ownership percentage.

Beneficial owners

Individuals who ultimately own or control the company.

Board (2)